Leukemic stem cells and therapy resistance in acute myeloid leukemia

Haematologica·Feb 1

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are studying the role of leukemic stem cells in therapy resistance in acute myeloid leukemia, exploring various factors and potential therapeutic targets. Findings suggest that targeting specific molecules, cellular mechanisms, and interactions with the bone marrow niche may help overcome treatment resistance. The discovery of these potential vulnerabilities is opening up new avenues for developing more effective therapies for acute myeloid leukemia.

Full coverage

Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia

Nature·Apr 21

Differentiation therapy in acute myeloid leukaemia: molecular basis, clinical progress, and future perspectives

Frontiers·May 18

Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance

Medical Xpress·May 7

Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia

Science | AAAS·Oct 15

Targeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy

Nature·Dec 1

Crosstalk of factors underlying bone marrow niche-mediated chemoprotection in acute myeloid leukemia

Frontiers·May 27

One protein may hold the key to fixing leukemia treatment failure

ScienceDaily·Nov 24

Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition

Nature·Mar 19

View original report at Haematologica ↗

Fetching the latest headlines…